Ceragenix Pharmaceuticals, Inc. Release: Research On Ceragenins To Be Highlighted At Leading International Conference On Infectious Disease

Published: Sep 20, 2006

DENVER--(BUSINESS WIRE)--Sept. 20, 2006--Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today announced that Dr. Paul Savage, Professor of Chemistry in the Department of Chemistry at Brigham Young University, has been selected to be the opening speaker during the "All New Antimicrobial Agents" session of the 46th annual meeting of the American Society for Microbiology's (ASM's) Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which is being held at the Moscone Center in San Francisco from September 27 - 29, 2006.

Back to news